Stamford, CT -- (SBWIRE) -- 01/28/2014 -- Wall Street Pennies is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT), ThermoGenesis Corp (NASDAQ:KOOL), Geron Corporation (NASDAQ:GERN), D.R. Horton, Inc. (NYSE:DHI).
Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT) opened its last trade at the price of $2.06. Its closing price was $2.06 after losing -3.29% for the day. The company traded with the total volume of 4.10 million shares, while its average trading volume remained 4.13 million shares. The beta of this stock stands at 0.66. Provectus Biopharmaceuticals, Inc., a development-stage pharmaceutical company, engages in developing pharmaceuticals for oncology and dermatology indications.
Has PVCT Found The Bottom and Ready To Move Up? Find Out Here
ThermoGenesis Corp (NASDAQ:KOOL) percentage change plunged -13.12% to close at $2.45 with the total traded volume of 4.41 million shares, along with average volume of 2.10 million shares. The 52 week range of the stock remained $0.71 - $3.24, while its day lowest price was $2.31. The share price hit the day highest price of $2.80. ThermoGenesis Corp. designs, develops, and commercializes devices and disposable tools for the processing, storage, and administration of cell therapies. The company provides automated and semi-automated devices, and single-use processing disposables that enable hospitals and blood banks to manufacture a therapeutic dose of stem cells.
Has KOOL Found The Bottom And Ready To Gain Momentum? Find Out Here
Geron Corporation (NASDAQ:GERN) traded on volume of 11.15 million shares in the last session against average volume of 4.74 million shares. The company started its trading session with the price of $5.04 and closed at $4.76 by scoring -15.30%. Geron Corporation is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California.
Why Should Investors Buy GERN After the Recent Fall? Just Go Here and Find Out
D.R. Horton, Inc. (NYSE:DHI) started its last trading session with the price of $21.01 and closed at $20.94 by scoring +0.29%. The stock traded with total volume of 10.67 million shares, while the average trading volume remained 6.10 million shares. The beta value of this stock stands at 1.00. Day range for the stock was $20.20 - $21.48. D.R. Horton, Inc. operates as a homebuilding company. It is engaged in the acquisition and development of land; and construction and sale of residential homes in 27 states and 78 markets in the United States under the D.R. Horton, America’s Builder, Emerald Homes, and Breland Homes.
For How Long DHI will Fight for Profitability? Read This Trend Analysis report
About Wall Street Pennies:
Wall Street Pennies is always penetrating the market every day for enormous penny stock runs before they happen in order to assist its customers. Our Penny Stock Newsletter also offers free market strategies and analysis from one of the most experienced and well-respected chartists in the penny stock industry.
Carriage Consulting Group, www.wallstreetpennies.com,, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “www.wallstreetpennies.com,”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. Wall Street Pennies as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by www.wallstreetpennies.com, as defined.
Read full Disclaimer at: http://wallstreetpennies.com/financial-disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)